郭智谭晓华高锦楼金星刘晓东何学鹏目的探讨C1K治疗耐药性非霍奇金淋巴瘤的效果。方法对5例经病理确诊为非霍奇金淋巴瘤且存在化疗耐药、多处结外器官侵犯的患者进行CIK治疗并观察治疗前后侵犯部位肿块的变化。结果所有患者通过影像学复査显示肿瘤明显缩小，2例多发侵犯性患者治疗前后显示完全消失。结论CIK细胞治疗耐药性非霍奇金淋巴瘤安全有效，为耐药性非霍奇金淋巴瘤的治疗提供了1种新的有效的免疫治疗手段。应用CIK细胞将是难治性或耐药性非霍奇金淋巴瘤治疗的1个新的重要方向。CIK;非霍奇金淋巴瘤;免疫治疗中图分类号:R.2文献标识码:A文章编号：-()01--02TheCurativeEffectToObserveCytokineInducedKillerTreatmentToleranceNon-HodgkinLymphomaGUOZhi,TANXiao-hua,GAOJi)i9etal.GeneralHospital^BeijingMilitaryArea^Beijing,ObjectiveTodiscusstheeffectofcytokineinducedkillerTreatmenttolerancenon-Hodgkinlymphoma.Method?sCollect5casefinaldiagnosisnon-Hodgkinlymphomawithpathology,andexistencedrugresistance^manyOrganstooffend,pro?cesscytokineinducedkillerTreatmentandObservingtumour^sChangeoftrespassonpartintreatment.ResultsAllpatiensreviewwithscreenagediplaydiminutionoftumour,2casemultiinvasivepatiendiplayextinction孩子便秘我之过多囊肾相关问答
